Loading provider…
Loading provider…
Hematology & Oncology Physician in San Diego, CA
NPI: 1275504466Primary Employer
Nmc San Diego
health.mil
HQ Phone
Get M.D. Preston's Phone NumberMobile
Get M.D. Preston's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1992 - 2027

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University Of Minnesota Medical School
med.umn.edu
Medical School
Until 1989
Naval Medical Center (San Diego)
Fellowship • Hematology and Medical Oncology
1992 - 1995
Residency • Internal Medicine
1989 - 1992
Internship • Internal Medicine
1989 - 1990
Authors: Gable, P S, Le, D T, McGehee, W, Rapaport, S I
Journal: Blood Coagul Fibrinolysis
Authors: Chandra Belani
Journal: Cancer
Maintenance therapy (MT) with weekly paclitaxel improves outcome for advanced non-small cell lung cancer (NSCLC) patients.
Authors: Chandra Belani
Publication Date: 2005-06
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Bevacizumab, DRUG: Paclitaxel, DRUG: Ixabepilone, DRUG: Nab-paclitaxel
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: RADIATION: radiation therapy, DRUG: dexamethasone, DRUG: doxorubicin hydrochloride, DRUG: methotrexate, DRUG: cyclophosphamide, DRUG: vincristine sulfate, DRUG: mercaptopurine, DRUG: cytarabine, DRUG: thioguanine, DRUG: daunorubicin hydrochloride, DRUG: pegaspargase
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), SWOG Cancer Research Network, Eastern Cooperative Oncology Group, NCIC Clinical Trials Group
Intervention / Treatment: DRUG: docetaxel, PROCEDURE: surgery, DRUG: LHRH agonist